Last updated on May 2020

Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients

Brief description of study

This study is designed to evaluate the safety, tolerability, pharmacokinetics and therapeutic efficacy of treatment with either VAY736 or CFZ533 in patients with SLE to enable further development of these compounds as treatment in this disease population

Clinical Study Identifier: NCT03656562

Find a site near you

Start Over

Novartis Investigative Site

Budapest, Hungary
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.